Facebook
Twitter
Telegram
Fehler meldenLarimar Therapeutics Finanzdaten 2011-2024 | LRMR
Jahresabschluß Larimar Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
382 M | 153 M | 74.8 M | 147 M | 10.5 M | 11.6 M | 13 M | 9.03 M | 14.8 M | - | - | - | - |
Anteile |
43.9 M | 25.8 M | 17.2 M | 9.38 M | 9.38 M | 2.69 M | 2.29 M | 2.27 M | 2.23 M | - | - | - | - |
Kurshistorie |
8.7 | 5.93 | 4.36 | 17.1 | 1.14 | 4.47 | 7.86 | 3.97 | 6.26 | 38.6 | - | - | - |
Nettogewinn |
-36.9 M | -35.4 M | -50.6 M | -42.5 M | -45.4 M | -61.4 M | -52 M | -57.9 M | -74.3 M | - | - | - | - |
Umsatz |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-41.8 M | -36.5 M | -50.5 M | -42.8 M | -23.2 M | -61.1 M | -53 M | -58.2 M | -73.8 M | -35.5 M | -13.8 M | -13.8 M | - |
Zinsaufwendungen |
- | - | - | - | 1.77 M | 1.9 M | 165 K | 529 K | 806 K | 870 K | - | 97 K | - |
EBITDA |
-41.4 M | -36.2 M | -50.1 M | -42.6 M | -45.4 M | -60.9 M | -52.8 M | -58 M | -73.7 M | - | - | - | - |
Betriebsaufwand |
41.8 M | 36.5 M | 50.5 M | 42.8 M | 45.7 M | 61.1 M | 53 M | 58.2 M | 73.8 M | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
14.1 M | 12.3 M | 12.1 M | 11.4 M | 16.2 M | 13.2 M | 12.2 M | 18.3 M | 19.2 M | - | - | - | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Larimar Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
53.6 M | 43.9 M | 43.9 M | 43.9 M | 43.9 M | 43.3 M | 22.2 M | 18.3 M | 18.3 M | 17.7 M | 18.3 M | 16 M | 16 M | 15.4 M | 16 M | 9.38 M | 6.09 M | 37.4 M | 6.09 M | 6.09 M | 37.3 M | 37 M | 36.6 M | 27.6 M | 27.5 M | 27.5 M | 27.5 M | 27.4 M | 27.4 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.2 M | 27.1 M | 27 M | 25.6 M | 22.8 M | 22.7 M | 2.18 M | 729 K | 729 K | 729 K | 729 K | 728 K | - | - | - | - | - | - | - | - |
Nettogewinn |
-14.7 M | - | -9.06 M | -8.37 M | -6.53 M | - | -8.32 M | -8.67 M | -8.94 M | - | -16.8 M | -12.6 M | -12.1 M | - | -10.3 M | -11.3 M | -6.67 M | -7.25 M | -8.63 M | -3.7 M | -4.72 M | -14.6 M | -15.1 M | -15.8 M | -16 M | -13.1 M | -12.6 M | -13.3 M | -13 M | -10.4 M | -14.7 M | -15 M | -17.7 M | -23.2 M | -19.9 M | -17.8 M | -13.5 M | -10.9 M | -14.7 M | -6.4 M | -4.46 M | -3.9 M | -3.5 M | -3.14 M | -3.59 M | - | - | - | - | - | - | - | - |
Umsatz |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-16.7 M | - | -10.3 M | -9.62 M | -7.64 M | - | -8.51 M | -8.69 M | -8.89 M | - | -16.7 M | -12.5 M | -12.1 M | - | -10.3 M | -11.4 M | -6.67 M | - | -8.63 M | -3.7 M | -13.3 M | - | -15.2 M | -15.6 M | -15.7 M | - | -12.8 M | -13.5 M | -13.3 M | - | -14.8 M | -15.1 M | -17.9 M | - | -19.7 M | -17.6 M | -13.2 M | - | -14.4 M | -5.99 M | -4.52 M | - | -3.52 M | -2.98 M | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 301 K | - | 426 K | 478 K | 500 K | - | 475 K | 466 K | 458 K | - | 31 K | 53 K | 73 K | - | 132 K | 140 K | 160 K | - | 200 K | 213 K | 213 K | - | 213 K | 443 K | 2 K | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-16.7 M | - | - | - | -7.56 M | - | -8.27 M | -8.52 M | -8.8 M | - | -16.5 M | -12.4 M | -12 M | - | -10.2 M | -11.3 M | -6.65 M | - | -8.57 M | -3.67 M | -13.2 M | - | -15 M | -15.5 M | -15.7 M | - | -12.7 M | -13.4 M | -13.2 M | - | -14.7 M | -15 M | -17.8 M | - | -19.7 M | -17.6 M | -13.2 M | - | -14.4 M | -5.98 M | -4.52 M | - | -3.52 M | -2.97 M | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
16.7 M | - | 10.3 M | 9.62 M | 7.64 M | - | 8.51 M | 8.69 M | 8.89 M | - | 16.7 M | 12.5 M | 12.1 M | - | 10.3 M | 11.4 M | 6.67 M | 7.28 M | 8.63 M | 3.7 M | 13.3 M | 14.7 M | 15.2 M | 15.6 M | 15.7 M | 13.4 M | 12.8 M | 13.5 M | 13.3 M | 10.5 M | 14.8 M | 15.1 M | 17.9 M | 23.2 M | 19.7 M | 17.6 M | 13.2 M | 10.7 M | 14.4 M | 5.99 M | 4.52 M | 3.76 M | 3.52 M | 2.98 M | 3.52 M | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
3.8 M | - | 3.75 M | 3.74 M | 3.08 M | - | 2.93 M | 3.04 M | 3.08 M | - | 2.7 M | 3.44 M | 3.13 M | - | 3.42 M | 2.49 M | 1.67 M | - | 594 K | 576 K | 3.65 M | - | 3.34 M | 3.35 M | 3.27 M | - | 3.12 M | 3.01 M | 3.59 M | - | 4.83 M | 4.9 M | 5.36 M | - | 5.55 M | 5.08 M | 3.02 M | - | 2.28 M | 1.29 M | 1.25 M | - | 1.08 M | 1.01 M | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung